Neuroblastoma Treatment Market Analysis Report 2025-2035 - Regional Players and Local Manufacturers are Expected to Play an Important Role in Future Growth [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Immunotherapy, significantly boosting survival rates in high-risk cases, alongside gene therapies and CAR-T cell trials, is at the forefront. However, high treatment costs pose challenges, limiting access in low-resource areas. Key players like Novartis and Eli Lilly are spearheading innovation in effective therapies. As the market diversifies globally, particularly in Asia-Pacific, new trends in pediatric cancer treatments promise personalized, improved outcomes, enhancing market opportunities. Dublin, April 22, 2026 (GLOBE NEWSWIRE) -- The "Neuroblastoma Market - A Global and Regional Analysis: Focus on Treatment and Regional Analysis, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The competitive landscape of the global neuroblastoma market is diverse, with numerous players across different regions offering a wide range of products. Regional players and local manufacturers are expected to play an important role in the market's growth, especially as deman
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Novo Nordisk: Is The GLP-1 Golden Age Already Behind It? [Seeking Alpha]Seeking Alpha
- Here is why Eli Lilly (LLY) is Among the 8 Best Beginner Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- Samsung Biologics Reports First Quarter 2026 Financial Results [TheStreet.com]TheStreet.com
- Eli Lilly's Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's US$7b Kelonia Deal Reshapes Oncology And Valuation Story [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- 4/21/26 - Form 4
- LLY's page on the SEC website